Search Results

1 - 5 of 5
FAQ
On October 10, 2024, NHGRI hosted a pre-application webinar for the Population Genomic Screening in Primary Care NOFOs: RFA-HG-24-021, RFA-HG-24-022, and RFA-HG-24-023. These FAQs contain questions answered during that webinar.
… this pilot study on a small number of conditions. In other studies, return of secondary fundings has been done at the … recruited by members listed in the award.   Is this nation-wide recruitment or is recruitment limited to a specific … is desirable where possible. However, the final Network-wide Community Engagement Board participants and activities …
FAQ
Questions and answers to help applicants responding to the Pre-Application Webinar for the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program RFA-HG-24-026.
Tribute
A candid and kind genomics pioneer leaves a deep impact on NHGRI and the genomics community.
… was a long-time grantee and advisor of the National Human Genome Research Institute (NHGRI) and a major positive force … at the intersection of genome technology development, studies of human genomic variation, and bioinformatics, while … there was to know about linkage disequilibrium and association studies. She knew how to ask hard questions and …
Event
On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to provide an overview of three notice of funding opportunities (RFA-HG-24-001, PAR-24-106 and PAR-24-107). Questions were answered during the webinar.
… … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to … FAQs … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to … … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to …
FAQ
Questions and answers to help applicants responding to the ML/AI Tools to Advance Genomic Translational Research (MAGen) notice of funding opportunities (NOFOs): RFA-HG-24-004 and RFA-HG-24-005.
… during the course of the UG3 phase, the Consortium-wide cross validation plan will be developed anew and jointly …